Clinical Application of Transcatheter Arterial Injection of Spongia Gelatinosa and Iodized-oil Emulsion to Treat Hepatocellular Carcinoma with Arteriovenous Fistula
LI Jun1, LIAO Zheng-yin1, YOU Xin2, et al. Department of Oncology, West China Hospital, Sichuan University, Chengdu 610041, China
Objective:To study the clinical application of embolization therapy in treating hepatic arteriovenous fistula in hepatocellular carcinoma (HCC) by injection of spongia gelatinosa and iodized-oil emulsion. Methods: Thirty-eight patients with HCC and arteriovenous fistula were respectively treated with spongia gelatinosa and iodized-oil emulsion for arteriovenous fistula through catheter in liver artery before the routine interventional treatment for the tumor. Frequency of recanalization of shunt, complete occlusion of the shunt, side effects, complications, and survival rates were analyzed. Results: The occlusion rate of arteriovenous fistula after initial treatment was 94.7% (36/38), and the recanalization rate of 4 weeks after embolization was 5.56% (2/36), and no serious complication occurred. The survival rate was 94.7% (36/38) at 6 months, 60.5% (23/38) at 12 months, and 21.1% (8/38) at 24 months, respectively. Conclusion: Transcatheter arterial injection of spongia gelatinosa and iodized-oil emulsion can treat HCC with arteriovenous fistula safely and effectively.
【CateGory Index】： R735.7